High Cholesterol & Cardiovascular Study
Study Details
|
Ages |
18 years or older |
| Duration | Up to approximately 56 weeks in total, including a screening period of up to 14 days, a 52 week treatment period and a 10-day safety follow-up after the last dose. |
|
Compensation |
Participants are reimbursed for reasonable expenses associated with study visits. Contact our team for current amounts once the study opens. |
|
Eligibility |
See eligibility checklist below. Other criteria apply — our team will confirm whether this study is a good fit for you. |
|
Locations |
Ipswich, QLD |
Description
Elevated LDL cholesterol, often called "bad cholesterol", is one of the leading contributors to cardiovascular disease. For people who have already experienced a heart attack, stroke, or significant cardiovascular event, or who are at high risk of a first event, lowering LDL to recommended levels is an important part of reducing the risk of future serious events.
Despite a range of existing cholesterol-lowering treatments including statins, many people do not reach recommended LDL targets. This study investigated whether a new oral once-daily tablet, taken alongside existing cholesterol medication, could significantly reduce LDL cholesterol levels. The trial has now completed enrolment and its findings will contribute to the development of new treatment options in this area.
Why Join
New treatment option: Gain early access to an investigational blood pressure treatment at no cost.
Expert support: Receive lifestyle guidance and regular health monitoring from our clinical team throughout.
Reimbursement: All clinic visits are reimbursed for your time and reasonable travel costs.
Help others: Contribute to research that may help others living with high cholesterol and cardiovascular disease.
Footer note: Your privacy is important. All personal information will be kept strictly confidential.
Interested in similar studies?
This study is now closed to new participants.
Life Clinical Research regularly opens new trials across cardiovascular and metabolic conditions. Register your interest below and our team will be in touch when a relevant study becomes available at one of our Queensland sites.
Once you register, a member of our clinical team will contact you to discuss the study in more detail, answer any questions, and confirm whether you may be eligible for a screening visit.

